£490.00

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics for US Zip Codes

Price data last checked 136 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£490 today · cheaper than every other day in the last 11 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 197 days • 197 data points (No recent data available)

Historical
Generating forecast...
£490.00 £465.50 £475.30 £485.10 £494.90 £504.70 £514.50 13 July 2025 31 August 2025 19 October 2025 07 December 2025 25 January 2026

Price Distribution

Price distribution over 197 days • 1 price levels

Days at Price
197 days 0 49 99 148 197 £490 Days at Price

Price Analysis

Most common price: £490 (197 days, 100.0%)

Price range: £490 - £490

Price levels: 1 different prices over 197 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
09 January 2023
Listed Since
27 January 2023

Similar Products You Might Like

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in China
99% match

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in China

£495.00 14 Jan 2026
The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in Japan
99% match

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in Japan

£495.00 16 Dec 2025
The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in the United States
98% match

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in India
98% match

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in India

£515.00 07 Jan 2026
The 2025-2030 World Outlook for Prostate Cancer Nuclear Medicine Diagnostics
98% match

The 2025-2030 World Outlook for Prostate Cancer Nuclear Medicine Diagnostics

Out of Stock 10 Dec 2025
The 2025-2030 World Outlook for Prostate Cancer Treatments and Prevention
97% match

The 2025-2030 World Outlook for Prostate Cancer Treatments and Prevention

Out of Stock 11 Feb 2026
The 2025-2030 World Outlook for Prostate Cancer Treatments
97% match

The 2025-2030 World Outlook for Prostate Cancer Treatments

Out of Stock 07 Feb 2026
The 2013-2018 Outlook for Prostate Cancer Therapeutics in Africa
97% match

The 2013-2018 Outlook for Prostate Cancer Therapeutics in Africa

£325.00 06 Feb 2026
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics for US Zip Codes
97% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics for US Zip Codes

£490.00 14 Jan 2026
The 2016-2021 Outlook for Prostate Cancer Therapeutics in Japan
97% match

The 2016-2021 Outlook for Prostate Cancer Therapeutics in Japan

£595.00 08 Mar 2026
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in Japan
96% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in Japan

£495.00 13 Jan 2026
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in China
96% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in China

£495.00 09 Jan 2026
The 2023-2028 Outlook for Cancer Screenings for US Zip Codes
96% match

The 2023-2028 Outlook for Cancer Screenings for US Zip Codes

£490.00 25 Jan 2026
The 2023-2028 Outlook for Cancer Testing-Screening for US Zip Codes
96% match

The 2023-2028 Outlook for Cancer Testing-Screening for US Zip Codes

£490.00 14 Apr 2026
The 2023-2028 Outlook for Cancer Diagnostics Laboratory Tests for US Zip Codes
96% match

The 2023-2028 Outlook for Cancer Diagnostics Laboratory Tests for US Zip Codes

£490.00 25 Jan 2026
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in India
96% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in India

£515.00 12 Jan 2026
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in the United States
96% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics for US Zip Codes
95% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics for US Zip Codes

£490.00 15 Apr 2026
The 2023-2028 Outlook for Breast Cancer Diagnostic Products for US Zip Codes
95% match

The 2023-2028 Outlook for Breast Cancer Diagnostic Products for US Zip Codes

£490.00 14 Jan 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers for US Zip Codes
95% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers for US Zip Codes

£490.00 29 Jan 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing for US Zip Codes
95% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing for US Zip Codes

£490.00 19 Apr 2026
Imaging and Focal Therapy of Early Prostate Cancer (Current Clinical Urology)
95% match

Imaging and Focal Therapy of Early Prostate Cancer (Current Clinical Urology)

Springer

£93.38 04 Mar 2026
Prostate Cancer: Advancements in the Pathogenesis, Diagnosis and Personalized Therapy
95% match

Prostate Cancer: Advancements in the Pathogenesis, Diagnosis and Personalized Therapy

Springer

£129.07 28 Feb 2026
The 2023-2028 Outlook for Head and Neck Cancers for US Zip Codes
95% match

The 2023-2028 Outlook for Head and Neck Cancers for US Zip Codes

£490.00 29 Jan 2026